Skip to main content
SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. logo

SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603231 ISIN · CNE100006DV2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2024-01-15 Share Issue/Capital Cha…
Country CN China
Listing Shanghai Stock Exchange 603231

About SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD.

https://www.solbar.com/

SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. is a specialized manufacturer of high-quality soy protein ingredients. The company produces a comprehensive range of products, including soy protein isolates, functional concentrates, textured soy proteins, and soy fibers. These ingredients are utilized extensively in the global food and beverage sectors, serving applications in meat processing, plant-based alternatives, nutritional supplements, and bakery products. The company emphasizes the use of non-GMO raw materials and advanced processing technologies to ensure high functionality and nutritional value. Its operations focus on delivering consistent quality and technical support to meet the evolving demands of the health-conscious consumer market and industrial food production.

Recent filings

Filing Released Lang Actions
关于变更公司注册资本、公司类型、修改《公司章程》并办理工商变更登记的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from Ningbo Suobao Protein Technology Co., Ltd. regarding changes to the company's registered capital, company type, and amendments to the company's articles of association (company charter). It details the approval of the capital increase following the company's initial public offering (IPO) and listing on the Shanghai Stock Exchange, as well as specific amendments to the articles of association to reflect these changes and comply with relevant regulations. The document also mentions the authorization for the board to handle the registration changes with the market supervision department. There are no financial statements or detailed financial performance data included; rather, it is a formal corporate announcement about capital changes and governance documents. This fits the category of a Share Issue/Capital Change announcement (SHA). The document length is over 10,000 characters, indicating it is a full announcement, not a brief notice or a report publication announcement.
2024-01-15 Chinese
东吴证券股份有限公司关于宁波索宝蛋白科技股份有限公司以募集资金置换预先投入募集资金投资项目及已支付发行费用的自筹资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Dongwu Securities regarding Ningbo Suobao Protein Technology Co., Ltd.'s use of raised funds to replace self-raised funds previously invested in projects and paid issuance expenses. It references regulatory guidelines on the management and use of raised funds, includes detailed financial figures about the fundraising and project investments, and contains opinions from the board, supervisory committee, independent directors, and an accounting firm. The document is not a full annual or interim report, nor is it a simple announcement or certification. It is a specialized audit/verification report related to the use of raised funds and compliance with regulatory requirements. Therefore, it fits best under the category of Audit Report / Information (AR). Q1 2024
2024-01-15 Chinese
宁波索宝蛋白科技股份有限公司审计委员会工作细则
Governance Information Classification · 95% confidence The document is titled '审计委员会工作细则' which translates to 'Audit Committee Working Rules'. It details the structure, responsibilities, and procedures of the audit committee within the company Ningbo Suobao Protein Technology Co., Ltd. It includes governance and oversight functions related to auditing and internal controls but does not contain financial statements, audit opinions, or results of audits themselves. It is a governance-related document outlining internal rules and committee operations rather than an audit report or annual report. Therefore, it fits best under Governance Information (CGR). The document length is 2658 characters, which is relatively short and focused on governance rules rather than financial data or audit results.
2024-01-15 Chinese
宁波索宝蛋白科技股份有限公司董事会议事规则
Governance Information Classification · 100% confidence The document is titled "董事会议事规则" which translates to "Rules of Procedure for the Board of Directors" of 宁波索宝蛋白科技股份有限公司. It details the governance structure, duties, meeting procedures, and decision-making processes of the company's board of directors. There is no financial data, audit information, or report content. It is a governance document outlining internal rules and board operations. Therefore, it fits the category of Governance Information (CGR). The document length is over 10,000 characters, indicating it is a full document, not a brief announcement or notice.
2024-01-15 Chinese
宁波索宝蛋白科技股份有限公司股东大会网络投票实施细则
Governance Information Classification · 95% confidence The document is titled as rules for the implementation of online voting for the shareholders' meeting of Ningbo Suobao Protein Technology Co., Ltd. It details procedures, regulations, and technical aspects related to shareholder voting at the general meeting. There is no financial data, no report of results, no announcement of voting outcomes, nor any indication of a meeting presentation or transcript. The document is a procedural guideline related to governance and shareholder meeting operations. It is not an announcement of voting results (DVA), nor a proxy solicitation (PSI), nor a report publication announcement (RPA). Given the content focuses on internal rules and procedures for shareholder voting, it best fits under Governance Information (CGR). The document length is 3551 characters, which is relatively short but contains substantive procedural content, not just an announcement or notice.
2024-01-15 Chinese
宁波索宝蛋白科技股份有限公司以自筹资金预先投入募集资金投资项目及支付发行费用的鉴证报告
Audit Report / Information Classification · 95% confidence The document is a verification report issued by a certified public accounting firm (Da Hua Certified Public Accountants) regarding the use of self-raised funds to pre-invest in projects and pay issuance expenses related to the company's fundraising activities. It references compliance with regulatory guidelines from the China Securities Regulatory Commission and the Shanghai Stock Exchange concerning the management and use of raised funds. The document includes detailed financial figures about the fundraising, investment projects, and pre-investment amounts, and it is dated January 2, 2024. The nature of the document is a standalone audit or attestation report focused on a specific aspect of the company's fundraising and fund usage, rather than a full annual or interim financial report. It is not a general regulatory announcement, nor a simple report publication announcement, but a formal audit verification report. Therefore, it fits the category of an Audit Report / Information (AR). Q1 2024
2024-01-15 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.